Solutions
Biomedical Intelligence for Modern Research Teams
Discover how connected biomedical intelligence can support pharmaceutical, biotechnology and scientific research teams.
Solutions
Built for how different research teams work
Every team draws on the same connected evidence base — organized around the research challenges each one faces most often.
Pharmaceutical Companies
Large-scale programs need to track evidence across many disease areas, targets and compounds at once, often spread across disconnected internal and external sources.
Moving between disease, target and molecule evidence in one connected view may help teams keep context intact across a broad portfolio.
Biotechnology Companies
Smaller teams often need to move quickly from an early hypothesis to a well-supported research direction, without the resources to manually assemble evidence from many sources.
A connected view of genes, pathways and targets can help teams explore early-stage hypotheses alongside their supporting evidence in one place.
Academic Research
Researchers frequently need to trace connections across disease biology, genetics and published literature — work that can be time-consuming when evidence is scattered across separate databases.
Linking disease, gene and publication evidence together may help researchers navigate background literature and biological context more efficiently.
Rare Disease Research
Rare disease research often involves sparse, fragmented evidence spread thinly across genetics, case literature and mechanism studies.
Bringing together the available genetic, pathway and clinical evidence in one connected view may help researchers see what is known — and where evidence is limited — more clearly.
Precision Medicine
Precision medicine work depends on understanding how specific biomarkers, genetic variants and targets relate to particular patient populations.
Connected biomarker, gene and target evidence can help researchers explore these relationships without reassembling context from separate sources each time.
Translational Research
Moving from preclinical findings toward clinical relevance requires connecting molecular evidence with clinical study data — domains that are often managed in separate systems.
A shared connected view spanning pathway, target, molecule and clinical evidence may help bridge preclinical and clinical research contexts.
Medical Affairs
Medical affairs teams need to stay current on the evidence landscape for a given disease or compound, often synthesizing publications, clinical trial data and mechanism information.
A connected view of disease, molecule and clinical evidence can help teams stay oriented across a fast-moving evidence landscape.
Research Workflow
One connected path through the evidence
Whatever the starting point, teams can move from a disease through its genetic and molecular context to the clinical evidence around it — without switching tools along the way.
